{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:06:16Z","timestamp":1790402776556,"version":"4.1.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004410","name":"Scientific and Technological Research Council of Turkey","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ejps.2025.107021","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T19:36:10Z","timestamp":1737142570000},"page":"107021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Investigation of flurbiprofen pharmacokinetics in rats following dermal administration of optimized cyclodextrin-based nanogel"],"prefix":"10.1016","volume":"206","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6465-6450","authenticated-orcid":false,"given":"Ayse Nur","family":"Oktay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevin","family":"Celebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibel","family":"Ilbasmis-Tamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2025.107021_bib0001","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0168-3659(94)90235-6","article-title":"Estimation of the pore size and charge density in human cadaver skin","volume":"32","author":"Aguilella","year":"1994","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejps.2025.107021_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119435","article-title":"Advancement in nanogel formulations provides controlled drug release","volume":"584","author":"Ahmed","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107021_bib0003","first-page":"6","article-title":"Novel arena of nanocosmetics: applications and their remarkable contribution in the management of dermal disorders, topical delivery","volume":"5","author":"Ahuja","year":"2024","journal-title":"Fut. Trends Chall. Wounds"},{"key":"10.1016\/j.ejps.2025.107021_bib0004","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107021_bib0005","unstructured":"Aslan, C., Celebi, N., Degim, I., Atak, A., Aral, L., 2011. Development And Characterization Of Il-2 Loaded Chitosan-Tpp Nanogels."},{"key":"10.1016\/j.ejps.2025.107021_bib0006","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1208\/s12249-016-0662-4","article-title":"Development of interleukin-2 loaded chitosan-based nanogels using artificial neural networks and investigating the effects on wound healing in rats","volume":"18","author":"Aslan","year":"2017","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.ejps.2025.107021_bib0007","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3109\/10837450.2015.1026605","article-title":"A novel nanogel formulation of methotrexate for topical treatment of psoriasis: optimization, in vitro and in vivo evaluation","volume":"21","author":"Avasatthi","year":"2016","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejps.2025.107021_bib0008","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0928-0987(01)00167-1","article-title":"Novel mechanisms and devices to enable successful transdermal drug delivery","volume":"14","author":"Barry","year":"2001","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejps.2025.107021_bib0009","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3390\/pharmaceutics10030086","article-title":"Bioavailability enhancement of poorly water-soluble drugs via nanocomposites: formulation\u2013Processing aspects and challenges","volume":"10","author":"Bhakay","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107021_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-511X-8-6","article-title":"Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies","volume":"8","author":"Bhaskar","year":"2009","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.ejps.2025.107021_bib0011","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jconrel.2016.06.017","article-title":"DLS and zeta potential\u2013what they are and what they are not?","volume":"235","author":"Bhattacharjee","year":"2016","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejps.2025.107021_bib0012","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/pharmaceutics9020012","article-title":"Liposomal formulations in clinical use: an updated review","volume":"9","author":"Bulbake","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107021_bib0013","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0378-5173(92)90369-D","article-title":"Interaction of naproxen with \u00df-cyclodextrin in ground mixture","volume":"78","author":"\u00c7elebi","year":"1992","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107021_bib0014","first-page":"89","author":"\u00c7elebi","year":"2014","journal-title":"Nanojeller. A. Z\u0131rh-G\u00fcrsoy i\u00e7inde"},{"key":"10.1016\/j.ejps.2025.107021_bib0015","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.addr.2003.10.028","article-title":"Lipid vesicles and other colloids as drug carriers on the skin","volume":"56","author":"Cevc","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2025.107021_bib0016","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0378-5173(92)90146-S","article-title":"Improvement of oral bioavailability of carbamazepine by inclusion in 2-hydroxypropyl-\u03b2-cyclodextrin","volume":"85","author":"Choudhury","year":"1992","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107021_bib0017","article-title":"Synergistic applications of cyclodextrin-based systems and metal-organic frameworks in transdermal drug delivery for skin cancer therapy","author":"Claudia\u00e1 Canale","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ejps.2025.107021_bib0018","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jconrel.2019.06.005","article-title":"Crossing biological barriers with nanogels to improve drug delivery performance","volume":"307","author":"Cuggino","year":"2019","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejps.2025.107021_bib0019","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107021_bib0020","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijpharm.2004.01.033","article-title":"Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles","volume":"275","author":"Dillen","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107021_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08982104.2017.1391285","article-title":"Microfluidic preparation of drug-loaded PEGylated liposomes, and the impact of liposome size on tumour retention and penetration","volume":"29","author":"Dong","year":"2019","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ejps.2025.107021_bib0022","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0378-5173(88)90250-5","article-title":"A study of the inclusion complex of naproxen with \u03b2-cyclodextrin","volume":"48","author":"Erden","year":"1988","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107021_bib0023","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10717540490280697","article-title":"Lipid nano\/submicron emulsions as vehicles for topical flurbiprofen delivery","volume":"11","author":"Fang","year":"2004","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejps.2025.107021_bib0024","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.chemosphere.2013.02.005","article-title":"Cyclodextrins as complexation and extraction agents for pesticides from contaminated soil","volume":"91","author":"Flaherty","year":"2013","journal-title":"Chemosphere"},{"key":"10.1016\/j.ejps.2025.107021_bib0025","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jconrel.2019.02.011","article-title":"Supramolecular nanogels fabricated via host\u2013guest molecular recognition as penetration enhancer for dermal drug delivery","volume":"300","author":"Gao","year":"2019","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejps.2025.107021_bib0026","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1039\/C7NR04480A","article-title":"Enhanced topical delivery of dexamethasone by \u03b2-cyclodextrin decorated thermoresponsive nanogels","volume":"10","author":"Giulbudagian","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejps.2025.107021_bib0027","article-title":"Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery","volume":"22","author":"Gonzalez-Mira","year":"2010","journal-title":"Nanotechnology"},{"key":"10.1016\/j.ejps.2025.107021_bib0028","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jps.22271","article-title":"Potential use of nanostructured lipid carriers for topical delivery of flurbiprofen","volume":"100","author":"Gonz\u00e1lez-Mira","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107021_bib0029","article-title":"Hydrodynamic diameter and zeta potential of nanostructured lipid carriers: emphasizing some parameters for correct measurements","volume":"620","author":"Gordillo-Galeano","year":"2021","journal-title":"Collo. Surf. A: Physicochem. Eng. Aspects"},{"key":"10.1016\/j.ejps.2025.107021_bib0030","first-page":"1","article-title":"Application of mathematical models in drug release kinetics of carbidopa and levodopa ER tablets","volume":"6","author":"Gouda","year":"2017","journal-title":"J. Dev. Drugs"},{"key":"10.1016\/j.ejps.2025.107021_bib0031","first-page":"735","article-title":"A novel nanogel delivery of poly-\u03b1, \u03b2-polyasparthydrazide by reverse microemulsion and its redox-responsive release of 5-Fluorouridine","volume":"11","author":"Guo","year":"2016","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107021_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10965-017-1281-9","article-title":"Synthesis of polymeric nano\/microgels: a review","volume":"24","author":"Hamzah","year":"2017","journal-title":"J. Poly. Res."},{"key":"10.1016\/j.ejps.2025.107021_bib0033","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/03639040701833708","article-title":"Investigation of nanostructured lipid carriers for transdermal delivery of flurbiprofen","volume":"34","author":"Han","year":"2008","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2025.107021_bib0034","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijpharm.2012.08.040","article-title":"Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation","volume":"439","author":"Han","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107021_bib0035","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1359-0286(02)00117-1","article-title":"Biodegradable nanoparticles for drug delivery and targeting","volume":"6","author":"Hans","year":"2002","journal-title":"Curr. Opin. Solid State Mater. Sci."},{"key":"10.1016\/j.ejps.2025.107021_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10965-017-1246-z","article-title":"Dual-responsive semi-IPN copolymer nanogels based on poly (itaconic acid) and hydroxypropyl cellulose as a carrier for controlled drug release","volume":"24","author":"Hassanpour","year":"2017","journal-title":"J. Poly. Res."},{"key":"10.1016\/j.ejps.2025.107021_bib0037","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/978-0-387-49785-3_5","article-title":"Overcoming poor aqueous solubility of drugs for oral delivery","volume":"1","author":"Heimbach","year":"2007","journal-title":"Prodrugs: Chall. Rew. Part"},{"key":"10.1016\/j.ejps.2025.107021_bib0038","first-page":"265","article-title":"Effect of zeta potential on the properties of nano-drug delivery systems-a review (Part 2)","volume":"12","author":"Honary","year":"2013","journal-title":"Trop. J. Pharmaceut. Res."},{"key":"10.1016\/j.ejps.2025.107021_bib0039","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.idairyj.2007.10.009","article-title":"Structure and stability of nanogel particles prepared by internal cross-linking of casein micelles","volume":"18","author":"Huppertz","year":"2008","journal-title":"Int. Dairy. J."},{"key":"10.1016\/j.ejps.2025.107021_bib0040","doi-asserted-by":"crossref","first-page":"81","DOI":"10.22270\/ajprd.v6i3.390","article-title":"Preparation and evaluation of beta sitosterol nanogel: a carrier design for targeted drug delivery system","volume":"6","author":"Inamdar","year":"2018","journal-title":"Asian J. Pharmaceut. Res. Dev."},{"key":"10.1016\/j.ejps.2025.107021_bib0041","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijpharm.2008.02.016","article-title":"Novel method for stratum corneum pore size determination using positron annihilation lifetime spectroscopy","volume":"358","author":"Itoh","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107021_bib0042","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1016\/j.biomaterials.2014.03.001","article-title":"Click hydrogels, microgels and nanogels: emerging platforms for drug delivery and tissue engineering","volume":"35","author":"Jiang","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2025.107021_bib0043","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1002\/anie.200900441","article-title":"Nanogels as pharmaceutical carriers: finite networks of infinite capabilities","volume":"48","author":"Kabanov","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejps.2025.107021_bib0044","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.apsb.2015.07.003","article-title":"Insoluble drug delivery strategies: review of recent advances and business prospects","volume":"5","author":"Kalepu","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejps.2025.107021_bib0045","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.meatsci.2009.02.012","article-title":"Particle size analysis of lamb meat: effect of homogenization speed, comparison with myofibrillar fragmentation index and its relationship with shear force","volume":"82","author":"Karumendu","year":"2009","journal-title":"Meat Sci."},{"key":"10.1016\/j.ejps.2025.107021_bib0046","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3109\/03639045.2012.686509","article-title":"Formulation, characterization and in vitro\u2013in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery","volume":"39","author":"Kawadkar","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2025.107021_bib0047","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1080\/03639045.2020.1793998","article-title":"Systematic development and characterization of curcumin-loaded nanogel for topical application","volume":"46","author":"Kesharwani","year":"2020","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2025.107021_bib0048","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1002\/adv.21876","article-title":"Hydroxypropyl-\u03b2-cyclodextrin hybrid nanogels as nano-drug delivery carriers to enhance the solubility of dexibuprofen: characterization, in vitro release, and acute oral toxicity studies","volume":"37","author":"Khalid","year":"2018","journal-title":"Adv. Poly. Technol."},{"key":"10.1016\/j.ejps.2025.107021_bib0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.10.044","article-title":"Cyclodextrins and their pharmaceutical applications","volume":"329","author":"Loftsson","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107021_bib0050","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1016\/j.ijbiomac.2017.10.156","article-title":"Preparation and optimization of self-assembled chondroitin sulfate-nisin nanogel based on quality by design concept","volume":"107","author":"Mohtashamian","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejps.2025.107021_bib0051","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijpharm.2008.05.031","article-title":"Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes","volume":"361","author":"Mokhtar","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107021_bib0052","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijpharm.2012.02.038","article-title":"Cyclodextrin-based nanogels for pharmaceutical and biomedical applications","volume":"428","author":"Moya-Ortega","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107021_bib0053","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/j.carbpol.2011.11.005","article-title":"Cross-linked hydroxypropyl-\u03b2-cyclodextrin and \u03b3-cyclodextrin nanogels for drug delivery: physicochemical and loading\/release properties","volume":"87","author":"Moya-Ortega","year":"2012","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejps.2025.107021_bib0054","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ijpharm.2012.11.002","article-title":"Dexamethasone eye drops containing \u03b3-cyclodextrin-based nanogels","volume":"441","author":"Moya-Ortega","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107021_bib0055","unstructured":"MR, M., Danaei, M., Javanmard, R., Raji, M., Maherani, B., 2025 Nanoscale Lipidic Carrier Systems: importance of Preparation Method and Solvents."},{"key":"10.1016\/j.ejps.2025.107021_bib0056","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0928-0987(01)00093-8","article-title":"The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-\u03b2-cyclodextrin","volume":"13","author":"Mura","year":"2001","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejps.2025.107021_bib0057","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1021\/acs.molpharmaceut.7b00926","article-title":"Gellan nanohydrogels: novel nanodelivery systems for cutaneous administration of piroxicam","volume":"15","author":"Musazzi","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2025.107021_bib0058","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1590\/0001-3765201520130436","article-title":"Physicochemical, in vitro and in vivo evaluation of flurbiprofen microemulsion","volume":"87","author":"Naeem","year":"2015","journal-title":"Anais da Academia Brasileira de Ci\u00eancias"},{"key":"10.1016\/j.ejps.2025.107021_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2020.109478","article-title":"Effect of crosslinking density on thermoresponsive nanogels: a study on the size control and the kinetics release of biomacromolecules","volume":"124","author":"Navarro","year":"2020","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.ejps.2025.107021_bib0060","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/10717544.2016.1276232","article-title":"Basic concepts and recent advances in nanogels as carriers for medical applications","volume":"24","author":"Neamtu","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejps.2025.107021_bib0061","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s13346-021-00951-4","article-title":"Formulation and evaluation of transdermal nanogel for delivery of artemether","volume":"11","author":"Nnamani","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejps.2025.107021_bib0062","first-page":"196","article-title":"Insights to the phase solubility diagrams of flurbiprofen with inclusion complex","volume":"25","author":"Oktay","year":"2021","journal-title":"J. Res. Pharm."},{"key":"10.1016\/j.ejps.2025.107021_bib0063","article-title":"Cyclodextrin-based nanogel of flurbiprofen for dermal application: in vitro studies and in vivo skin irritation evaluation","volume":"79","author":"Oktay","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2025.107021_bib0064","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1080\/10837450.2019.1667384","article-title":"The effect of critical process parameters of the high pressure homogenization technique on the critical quality attributes of flurbiprofen nanosuspensions","volume":"24","author":"Oktay","year":"2019","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejps.2025.107021_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105548","article-title":"Preparation and in vitro\/in vivo evaluation of flurbiprofen nanosuspension-based gel for dermal application","volume":"155","author":"Oktay","year":"2020","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejps.2025.107021_bib0066","article-title":"Screening of stabilizing agents to optimize flurbiprofen nanosuspensions using experimental design","volume":"57","author":"Oktay","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2025.107021_bib0067","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s11095-021-03060-6","article-title":"Enhanced dermal delivery of flurbiprofen nanosuspension based gel: development and ex vivo permeation, pharmacokinetic evaluations","volume":"38","author":"Oktay","year":"2021","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107021_bib0068","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ejps.2018.07.009","article-title":"Dermal flurbiprofen nanosuspensions: optimization with design of experiment approach and in vitro evaluation","volume":"122","author":"Oktay","year":"2018","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejps.2025.107021_bib0069","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1208\/s12249-018-1196-8","article-title":"Skin penetration and permeation properties of Transcutol\u00ae\u2014Neat or diluted mixtures","volume":"19","author":"Osborne","year":"2018","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.ejps.2025.107021_bib0070","first-page":"12","article-title":"Release kinetics\u2013concepts and applications","volume":"8","author":"Paarakh","year":"2018","journal-title":"Int. J. Pharm. Res. Technol. (IJPRT)"},{"key":"10.1016\/j.ejps.2025.107021_bib0071","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mimet.2019.04.001","article-title":"Flurbiprofen-loaded ethanolic liposome particles for biomedical applications","volume":"161","author":"Paliwal","year":"2019","journal-title":"J. Microbiol. Methods"},{"key":"10.1016\/j.ejps.2025.107021_bib0072","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-019-1064-x","article-title":"Flurbiprofen loaded ethosomes-transdermal delivery of anti-inflammatory effect in rat model","volume":"18","author":"Paliwal","year":"2019","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.ejps.2025.107021_bib0073","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrd2591","article-title":"Strategies in the design of nanoparticles for therapeutic applications","volume":"9","author":"Petros","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2025.107021_bib0074","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/ardp.19943271109","article-title":"Complexation of Hydrocortison with \u03b2-Cyclodextrin and Hydroxypropyl-\u03b2-Cyclodextrin","volume":"327","author":"Preiss","year":"1994","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejps.2025.107021_bib0075","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.3390\/ijms25063527","article-title":"Exploring cyclodextrin-based nanosponges as drug delivery systems: understanding the physicochemical factors influencing drug loading and release kinetics","volume":"25","author":"Pyrak","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2025.107021_bib0076","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/chir.10314","article-title":"In vitro release and stereoselective disposition of flurbiprofen loaded to poly (D, l-lactide-co-glycolide) nanoparticles in rats","volume":"16","author":"Radwan","year":"2004","journal-title":"Chirality: Pharmacolog., Biolog., Chem. Conseq. Mol. Asym."},{"key":"10.1016\/j.ejps.2025.107021_bib0077","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0376-7388(92)85015-B","article-title":"Effect of crosslinking agent on the release of an aqueous marker from liposomes sequestered in collagen and chitosan gels","volume":"71","author":"Rao","year":"1992","journal-title":"J. Memb. Sci."},{"key":"10.1016\/j.ejps.2025.107021_bib0078","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11095-005-8924-y","article-title":"New cyclodextrin hydrogels cross-linked with diglycidylethers with a high drug loading and controlled release ability","volume":"23","author":"Rodriguez-Tenreiro","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107021_bib0079","article-title":"Drug solubility: importance and enhancement techniques","volume":"2012","author":"Savjani","year":"2012","journal-title":"Int. Sch. Res. Notices."},{"key":"10.1016\/j.ejps.2025.107021_bib0080","article-title":"The effect of cyclodextrins on the in vitro characteristics of semisolid formulations of all trans retinoic acid","volume":"10","author":"\u015een","year":"2013","journal-title":"Turk. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107021_bib0081","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.biomaterials.2011.11.011","article-title":"Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugs","volume":"33","author":"Shah","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2025.107021_bib0082","first-page":"399","article-title":"Nanocrystal for ocular drug delivery: hope or hype","volume":"6","author":"Sharma","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejps.2025.107021_bib0083","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jddst.2017.09.012","article-title":"Nanosuspensions based gel as delivery system of nitrofurazone for enhanced dermal bioavailability","volume":"43","author":"Shen","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2025.107021_bib0084","first-page":"62","article-title":"Macrogel and nanogel networks based on crosslinked poly (vinyl alcohol) for adsorption of methylene blue from aqua system","volume":"5","author":"Shoueir","year":"2016","journal-title":"Environ. Nanotechnol. Monit. Manage."},{"key":"10.1016\/j.ejps.2025.107021_bib0085","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/10837450.2019.1647235","article-title":"Key production parameters for the development of solid lipid nanoparticles by high shear homogenization","volume":"24","author":"Souto","year":"2019","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejps.2025.107021_bib0086","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijpharm.2013.10.004","article-title":"The influence of salt formation on electrostatic and compression properties of flurbiprofen salts","volume":"458","author":"\u0160upuk","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107021_bib0087","doi-asserted-by":"crossref","first-page":"e6406","DOI":"10.1002\/pat.6406","article-title":"Nanocarrier-embedded gels: precision drug delivery via liposomal and niosomal platforms","volume":"35","author":"Trucillo","year":"2024","journal-title":"Polym. Adv. Technol."},{"key":"10.1016\/j.ejps.2025.107021_bib0088","first-page":"41","article-title":"Solubility enhancement techniques","volume":"5","author":"Vemula","year":"2010","journal-title":"Int. J. Pharm. Sci. Rev. Res."},{"key":"10.1016\/j.ejps.2025.107021_bib0089","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0939-6411(98)00033-2","article-title":"Characterization of an inclusion complex of cholesterol and hydroxypropyl-\u03b2-cyclodextrin","volume":"46","author":"Williams","year":"1998","journal-title":"Eur. J. Pharmaceut. Biopharm."},{"key":"10.1016\/j.ejps.2025.107021_bib0090","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0168-3659(02)00056-1","article-title":"Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration","volume":"81","author":"Wissing","year":"2002","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejps.2025.107021_bib0091","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.148840","article-title":"Dissolving microneedle-mediated transdermal delivery of flurbiprofen axetil-loaded pH-responsive liposomes for arthritis treatment","volume":"482","author":"Xie","year":"2024","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.ejps.2025.107021_bib0092","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123065","article-title":"Size-dependence of the skin penetration of andrographolide nanosuspensions: in vitro release-ex vivo permeation correlation and visualization of the delivery pathway","volume":"641","author":"Yao","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107021_bib0093","article-title":"Preparation of thermoresponsive triclosan poly (N-isopropylacrylamide) nanogels and evaluation of antibacterial efficacy on Cutibacterium acnes","volume":"76","author":"Yurdasiper","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2025.107021_bib0094","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.addr.2013.05.001","article-title":"Cyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspective","volume":"65","author":"Zhang","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2025.107021_bib0095","first-page":"924","article-title":"Effect of surfactant concentration on the particle size, stability and potential zeta of beta carotene nano lipid carrier","volume":"4","author":"Zirak","year":"2015","journal-title":"Int. J. Curr. Microbiol. Appl. Sci."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809872500020X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809872500020X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T15:16:03Z","timestamp":1755011763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092809872500020X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":95,"alternative-id":["S092809872500020X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107021","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of flurbiprofen pharmacokinetics in rats following dermal administration of optimized cyclodextrin-based nanogel","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107021"}}